Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334347 · ClinicalTrials.gov registry record · Phase 4
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT00334347: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00334347 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00334347, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To compare the time to response, response rates, remission rates, and side effects in Bipolar Disorder inpatients treated with Depakote ER or Depakote DR for acute mania or mixed mania.
Interventions
- DRUG Depakote ER
- DRUG Depakote DR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00334347
The ClinicalTrials.gov registry entry for NCT00334347 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Depakote ER is the first listed.
NCT00334347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00334347 about?
NCT00334347 is a clinical study titled "A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR". To compare the time to response, response rates, remission rates, and side effects in Bipolar Disorder inpatients treated with Depakote ER or Depakote DR for acute mania or mixed mania.
What is the current status of trial NCT00334347?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2006-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00334347?
The interventions under investigation include: Depakote ER (DRUG), Depakote DR (DRUG).
Who is sponsoring clinical trial NCT00334347?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.